Pages that link to "Q50771817"

The following pages link to A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network. (Q50771817):

Displayed 50 items.

• Chromatin dynamics during cellular reprogramming (Q27003401) ‎ (← links)
• CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming (Q27333857) ‎ (← links)
• Lin28: primal regulator of growth and metabolism in stem cells (Q28288454) ‎ (← links)
• Toward pluripotency by reprogramming: mechanisms and application (Q28833688) ‎ (← links)
• Mechanisms for enhancing cellular reprogramming (Q33943321) ‎ (← links)
• Molecular control of induced pluripotency (Q33957979) ‎ (← links)
• C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells. (Q34039326) ‎ (← links)
• Divergent reprogramming routes lead to alternative stem-cell states (Q34042718) ‎ (← links)
• Transcriptional profiling of cells sorted by RNA abundance (Q34240933) ‎ (← links)
• Cell signalling pathways underlying induced pluripotent stem cell reprogramming (Q34259132) ‎ (← links)
• Mechanisms and models of somatic cell reprogramming (Q34345169) ‎ (← links)
• Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes (Q34360620) ‎ (← links)
• A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential (Q34697724) ‎ (← links)
• The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells (Q34729447) ‎ (← links)
• X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency (Q34803951) ‎ (← links)
• Two miRNA clusters reveal alternative paths in late-stage reprogramming (Q35009852) ‎ (← links)
• Collaborative rewiring of the pluripotency network by chromatin and signalling modulating pathways (Q35139931) ‎ (← links)
• Single cell analysis reveals the stochastic phase of reprogramming to pluripotency is an ordered probabilistic process (Q35152234) ‎ (← links)
• FAS-based cell depletion facilitates the selective isolation of mouse induced pluripotent stem cells (Q35207724) ‎ (← links)
• KLF4 N-terminal variance modulates induced reprogramming to pluripotency (Q35453993) ‎ (← links)
• Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming (Q35486433) ‎ (← links)
• Early reprogramming regulators identified by prospective isolation and mass cytometry (Q35637427) ‎ (← links)
• CD24 tracks divergent pluripotent states in mouse and human cells (Q35813679) ‎ (← links)
• Maternal histone variants and their chaperones promote paternal genome activation and boost somatic cell reprogramming. (Q35837673) ‎ (← links)
• Asymmetric Regulation of Peripheral Genes by Two Transcriptional Regulatory Networks (Q36092444) ‎ (← links)
• Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State (Q36407341) ‎ (← links)
• Mechanisms underlying the formation of induced pluripotent stem cells (Q36469676) ‎ (← links)
• An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency (Q36588918) ‎ (← links)
• NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming. (Q36671866) ‎ (← links)
• Epigenetics of reprogramming to induced pluripotency (Q36700557) ‎ (← links)
• Cell surface marker mediated purification of iPS cell intermediates from a reprogrammable mouse model. (Q36788083) ‎ (← links)
• Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency (Q37071550) ‎ (← links)
• MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. (Q37601795) ‎ (← links)
• Gender Differences in Global but Not Targeted Demethylation in iPSC Reprogramming. (Q37634516) ‎ (← links)
• Mathematical approaches to modeling development and reprogramming (Q37702110) ‎ (← links)
• Vectorology and factor delivery in induced pluripotent stem cell reprogramming. (Q38195650) ‎ (← links)
• Cancer: pathological nuclear reprogramming? (Q38230318) ‎ (← links)
• Systematic identification of barriers to human iPSC generation (Q38305710) ‎ (← links)
• Autophagy and cell reprogramming (Q38311807) ‎ (← links)
• Werner Syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming (Q38358089) ‎ (← links)
• Fluctuations in histone H4 isoforms during cellular reprogramming monitored by middle-down proteomics. (Q38409728) ‎ (← links)
• An improved method for the derivation of high quality iPSCs in the absence of c-Myc (Q38446399) ‎ (← links)
• Identification of Ccr4-not complex components as regulators of transition from partial to genuine induced pluripotent stem cells (Q38483743) ‎ (← links)
• Small molecules for reprogramming and transdifferentiation (Q38658879) ‎ (← links)
• Molecular features of cellular reprogramming and development (Q38736146) ‎ (← links)
• Rational Development of A Polycistronic Plasmid with A CpG-Free Bacterial Backbone as A Potential Tool for Direct Reprogramming. (Q38775692) ‎ (← links)
• Identification of SSEA-1 expressing enhanced reprogramming (SEER) cells in porcine embryonic fibroblasts (Q38828827) ‎ (← links)
• Cell fate conversion-from the viewpoint of small molecules and lineage specifiers (Q38951137) ‎ (← links)
• Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage (Q38951765) ‎ (← links)
• KATapulting toward Pluripotency and Cancer (Q38976614) ‎ (← links)